-
Treatment of perimenstrual migraine with triptans: an update.
Current pain and headache reports 20121001
-
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
The journal of headache and pain 20120701
-
Stability, responsiveness, and reproducibility of a visual analog scale for treatment satisfaction in migraine.
Headache 20120601
-
Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
Applied health economics and health policy 20120501
-
Oral sumatriptan and almotriptan--delimiting the MAOI effect.
Headache 20120501
-
LC-ESI-MS/MS determination of in vivo metabolites of almotriptan in rat plasma, urine and feces: application to pharmacokinetics.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120401
-
The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the 'Act when mild' study.
The International journal of neuroscience 20111201
-
Effect of iontophoresis on in vitro transdermal absorption of almotriptan.
International journal of pharmaceutics 20110915
-
Almotriptan for menstrually related migraine.
Expert opinion on pharmacotherapy 20110801
-
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.
The journal of headache and pain 20110601
-
Improved patient satisfaction and pain evolution with almotriptan in migraine: a primary care study.
Current medical research and opinion 20110301
-
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Cephalalgia : an international journal of headache 20110101
-
Almotriptan for the acute treatment of adolescent migraine.
Expert opinion on pharmacotherapy 20101001
-
Almotriptan: a review of 10 years' clinical experience.
Expert review of neurotherapeutics 20101001
-
Almotriptan efficacy in migraine with allodynia: a rebuttal to Burstein and Jakubowski's critique of Schoenen et al.
Cephalalgia : an international journal of headache 20100901
-
Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.
Expert review of neurotherapeutics 20100901
-
Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601
-
Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study.
International journal of clinical practice 20100601
-
Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
Headache 20100501
-
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
European journal of clinical pharmacology 20100401
-
Almotriptan for the treatment of acute migraine: a review of early intervention trials.
Expert review of neurotherapeutics 20100301
-
[Acute migraine: a treatment reserved for adults now recommended for adolescents].
Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20100101
-
Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.
Cephalalgia : an international journal of headache 20091001
-
Variation in almotriptan effectiveness according to different prophylactic treatments.
Headache 20091001
-
Migraine treatment with rizatriptan and almotriptan: a crossover study.
Headache 20090501
-
[Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].
Neurologia (Barcelona, Spain) 20090401
-
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
Headache 20090301
-
Almotriptan efficacy in migraine with developing allodynia is as high as the efficacy in migraine without allodynia--but is it the same in migraine with established allodynia?
Headache 20090301
-
Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Headache 20081001
-
Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.
Cephalalgia : an international journal of headache 20081001
-
Seizure after use of almotriptan.
Clinical neurology and neurosurgery 20080901
-
Almotriptan in triptan-naïve patients: new evidence of benefits.
Cephalalgia : an international journal of headache 20080901
-
The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Cephalalgia : an international journal of headache 20080901
-
Applying the benefits of the AwM study in the clinic.
Cephalalgia : an international journal of headache 20080901
-
Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Cephalalgia : an international journal of headache 20080401
-
A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
Journal of pharmaceutical and biomedical analysis 20080313
-
Migraine-like headache in intracranial haemorrhage is alleviated by sumatriptan and almotriptan.
Cephalalgia : an international journal of headache 20080301
-
Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Headache 20080301
-
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Headache 20080201
-
Almotriptan, an antimigraine agent, and its malate salt.
Acta crystallographica. Section C, Crystal structure communications 20080101
-
Almotriptan: meeting today's needs in acute migraine treatment.
Expert review of neurotherapeutics 20071201
-
Use of almotriptan in triptan-experienced and triptan-naïve patients.
Current medical research and opinion 20071001
-
Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
Headache 20070901
-
Do 5HT1B/1D receptor agonists have an effect on mood and anxiety disorders?
Cephalalgia : an international journal of headache 20070501
-
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Headache 20070401
-
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
European journal of neurology 20070301
-
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Headache 20070201
-
Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
Journal of neurology 20070201
-
Almotriptan and zolmitriptan in the acute treatment of migraine.
Acta neurologica Scandinavica 20070101
-
A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
Minerva medica 20061201
-
Disposition and metabolism of almotriptan in rats, dogs and monkeys.
Xenobiotica; the fate of foreign compounds in biological systems 20060901
-
Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers.
International journal of clinical pharmacology and therapeutics 20060901
-
Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20060501
-
Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Cephalalgia : an international journal of headache 20060401
-
Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial.
International journal of clinical pharmacology and therapeutics 20060401
-
Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety.
The journal of headache and pain 20060401
-
[Economic evaluation of acute migraine attack treatment with triptans in Spain].
Neurologia (Barcelona, Spain) 20060301
-
Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example.
The journal of headache and pain 20060201
-
Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study.
European neurology 20060101
-
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
International journal of clinical practice 20051101
-
Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Current medical research and opinion 20051001
-
Multiple attack study on the available triptans in Italy versus placebo.
European journal of neurology 20050701
-
Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
Headache 20050601
-
Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack.
Cephalalgia : an international journal of headache 20050501
-
Early triptan intervention in migraine: an overview.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501
-
Correlation between lipophilicity and triptan outcomes.
Headache 20050101
-
[Tolerance to almotriptan and its effectiveness in primary care].
Atencion primaria 20050101
-
Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.
Clinical pharmacokinetics 20050101
-
Efficacy and tolerability of almotriptan in controlled clinical trials.
European neurology 20050101
-
Efficacy and tolerability of almotriptan in postmarketing surveillance studies.
European neurology 20050101
-
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
European neurology 20050101
-
Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Headache 20050101
-
Pharmacokinetics and safety of oral almotriptan in healthy male volunteers.
Biopharmaceutics & drug disposition 20041001
-
Evaluating triptan usage: a rebuttal.
Headache 20041001
-
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
Acta neurologica Scandinavica 20040901
-
[Meta-analysis of triptan treatment in migraine].
No to shinkei = Brain and nerve 20040901
-
Meta-analysis of oral triptans.
Cephalalgia : an international journal of headache 20040801
-
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Naunyn-Schmiedeberg's archives of pharmacology 20040701
-
[Almotriptan. One more triptan for migraines].
Revue de l'infirmiere 20040601
-
Oral almotriptan: practical uses in the acute treatment of migraine.
Expert review of neurotherapeutics 20040501
-
A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.
Cephalalgia : an international journal of headache 20040401
-
Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Headache 20040401
-
Evaluating triptan usage.
Headache 20040201
-
A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.
Journal of managed care pharmacy : JMCP 20040101
-
Migraine pathophysiology and its clinical implications.
Cephalalgia : an international journal of headache 20040101
-
What do patients want from acute migraine treatment?
Cephalalgia : an international journal of headache 20040101
-
Clinical profile and practice experience of almotriptan.
Cephalalgia : an international journal of headache 20040101
-
Clinical benefits of early triptan therapy for migraine.
Cephalalgia : an international journal of headache 20040101
-
Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
Clinical therapeutics 20031101
-
A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
Expert opinion on pharmacotherapy 20030701
-
Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan.
Drug metabolism and disposition: the biological fate of chemicals 20030401
-
Interaction between ketoconazole and almotriptan in healthy volunteers.
Journal of clinical pharmacology 20030401
-
A case of carotidynia with response to almotriptan.
Cephalalgia : an international journal of headache 20030301
-
A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
Clinical therapeutics 20030201
-
[Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].
Neurologia (Barcelona, Spain) 20030101
-
Almotriptan versus rizatriptan in patients with migraine in Spain.
Headache 20030101
-
Early intervention with almotriptan improves sustained pain-free response in acute migraine.
Headache 20030101
-
Almotriptan: an effective and well-tolerated treatment for migraine pain.
Drugs of today (Barcelona, Spain : 1998) 20030101
-
Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
Journal of clinical pharmacology 20021201
-
Efficacy and safety of almotriptan malate for migraine.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021115
-
New medications show promise for migraine sufferers.
Dentistry today 20021001
-
Mechanisms of action of the 5-HT1B/1D receptor agonists.
Archives of neurology 20020701
-
Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
Cephalalgia : an international journal of headache 20020701
-
New drugs 2002, part III.
Nursing 20020701
-
Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute migraine.
Clinical therapeutics 20020401
-
Triptan medications to treat acute migraine.
Lancet (London, England) 20020330
-
Triptan medications to treat acute migraine.
Lancet (London, England) 20020330
-
Triptan medications to treat acute migraine.
Lancet (London, England) 20020330
-
Cardiovascular effect of almotriptan in treated hypertensive patients.
Clinical pharmacology and therapeutics 20020301
-
Almotriptan (Axert) and frovatriptan (Frova) for migrane.
The Medical letter on drugs and therapeutics 20020218
-
Cost savings in migraine associated with less chest pain on new triptan therapy.
The American journal of managed care 20020201
-
Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
The American journal of managed care 20020201
-
Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
The American journal of managed care 20020201
-
Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms.
The American journal of managed care 20020201
-
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
Headache 20020201
-
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Ideggyogyaszati szemle 20020120
-
Almotriptan: a review of its use in migraine.
Drugs 20020101
-
Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
Headache 20020101
-
Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.
Headache 20020101
-
Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan.
Headache 20020101
-
Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
Headache 20020101
-
Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better.
Headache 20020101
-
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
Headache 20020101
-
Spotlight on almotriptan in migraine.
CNS drugs 20020101
-
Almotriptan, a new anti-migraine agent: a review.
CNS drug reviews 20020101
-
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine.
Neurology 20011127
-
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Lancet (London, England) 20011117
-
Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
Clinical therapeutics 20011101
-
Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries.
Cephalalgia : an international journal of headache 20011001
-
Safety profile of almotriptan, a new antimigraine agent. Effects on central nervous system, renal function and respiratory dynamics.
Arzneimittel-Forschung 20010901
-
[Migraine headache. Severe attacks: triptans are essential].
MMW Fortschritte der Medizin 20010719
-
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
Archives of neurology 20010701
-
Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
Archives of neurology 20010601
-
Oral almotriptan in the treatment of migraine: safety and tolerability.
Headache 20010501
-
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans.
British journal of clinical pharmacology 20010501
-
[Current topics: expectation for new triptans].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410
-
Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers.
Journal of cardiovascular pharmacology 20010301
-
Acute treatment of migraine and the role of triptans.
Current neurology and neuroscience reports 20010301
-
Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers.
Journal of clinical pharmacology 20010201
-
Almotriptan: a balanced approach to migraine.
Hospital medicine (London, England : 1998) 20010201
-
Lack of pharmacokinetic interaction between the antimigraine compound, almotriptan, and propranolol in healthy volunteers.
Cephalalgia : an international journal of headache 20010201
-
Long-term efficacy and safety of oral almotriptan: interim analysis of a 1-year open study.
Headache 20010101
-
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
Clinical therapeutics 20010101
-
Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
European neurology 20010101
-
Almotriptan: pharmacological differences and clinical results.
Current medical research and opinion 20010101
-
Comparative aspects of triptans in treating migraine.
Clinical cornerstone 20010101
-
Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
European journal of pharmacology 20001220
-
Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine.
European journal of pharmacology 20001220
